Takeda Pharmaceutical Co Ltd (WBO:TKD)
€ 30.77 -0.11 (-0.36%) Market Cap: 50.04 Bil Enterprise Value: 72.79 Bil PE Ratio: 0 PB Ratio: 1.24 GF Score: 19/100

Q1 2027 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript

Jul 30, 2026 / 10:00 AM GMT


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

4502.T - Takeda Pharmaceutical Co Ltd
Q1 2027 Takeda Pharmaceutical Co Ltd Earnings Presentation
Jul 30, 2026 / 10:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
For those who listen to this call in English, please select English in the Zoom language select button.

Before starting, I'd like to remind everyone that we'll be discussing forward-looking statements within the meaning of the Private Litigation Reform Act of 1,995.

Actual results may differ materially from those discussed today, the factors that could cause our actual thoughts to differ materially are discussed in our most recent form, 20, and in our other filings.

Please also refer to the important notice on page 2 of the presenting forward-looking statements and our non IFRS financial measures, which will be also in the score, definitions of a non-diverse measures and
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot